Shijiazhuang Yiling Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
Shijiazhuang Yiling Pharmaceutical has a total shareholder equity of CN¥11.5B and total debt of CN¥1.3B, which brings its debt-to-equity ratio to 11%. Its total assets and total liabilities are CN¥17.0B and CN¥5.5B respectively. Shijiazhuang Yiling Pharmaceutical's EBIT is CN¥319.5M making its interest coverage ratio 30.7. It has cash and short-term investments of CN¥1.2B.
Key information
11.0%
Debt to equity ratio
CN¥1.26b
Debt
| Interest coverage ratio | 30.7x |
| Cash | CN¥1.22b |
| Equity | CN¥11.46b |
| Total liabilities | CN¥5.49b |
| Total assets | CN¥16.95b |
Recent financial health updates
Is Shijiazhuang Yiling Pharmaceutical (SZSE:002603) Using Too Much Debt?
Sep 25
Is Shijiazhuang Yiling Pharmaceutical (SZSE:002603) A Risky Investment?
May 26Recent updates
Is Shijiazhuang Yiling Pharmaceutical (SZSE:002603) Using Too Much Debt?
Sep 25Shijiazhuang Yiling Pharmaceutical Co., Ltd.'s (SZSE:002603) Subdued P/S Might Signal An Opportunity
Aug 07Shijiazhuang Yiling Pharmaceutical (SZSE:002603) Has Announced That Its Dividend Will Be Reduced To CN¥0.30
Jul 15Is Shijiazhuang Yiling Pharmaceutical (SZSE:002603) A Risky Investment?
May 26Weak Statutory Earnings May Not Tell The Whole Story For Shijiazhuang Yiling Pharmaceutical (SZSE:002603)
May 05Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SZSE:002603) Analysts Just Cut Their EPS Forecasts Substantially
May 02Should You Be Adding Shijiazhuang Yiling Pharmaceutical (SZSE:002603) To Your Watchlist Today?
Mar 01Financial Position Analysis
Short Term Liabilities: 002603's short term assets (CN¥6.5B) exceed its short term liabilities (CN¥4.4B).
Long Term Liabilities: 002603's short term assets (CN¥6.5B) exceed its long term liabilities (CN¥1.1B).
Debt to Equity History and Analysis
Debt Level: 002603's net debt to equity ratio (0.3%) is considered satisfactory.
Reducing Debt: 002603's debt to equity ratio has increased from 0% to 11% over the past 5 years.
Debt Coverage: 002603's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 002603's interest payments on its debt are well covered by EBIT (30.7x coverage).